Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
-
- Sandra P. D’Angelo
- Department of Medicine, Weill Cornell Medical College, New York, New York
-
- Jeffery Russell
- H. Lee Moffitt Cancer Center, Tampa, Florida
-
- Céleste Lebbé
- Assistance Publique–Hôpitaux de Paris Dermatology and Centre d’Investigation Clinique, University Paris Diderot Institut National de la Santé et de la Recherche Medicale U976, Saint Louis Hospital, Paris, France
-
- Bartosz Chmielowski
- Department of Medicine, UCLA (University of California, Los Angeles) Medical Center
-
- Thilo Gambichler
- Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany
-
- Jean-Jacques Grob
- Department of Dermatology, Venerology, and Cutaneous Oncology, Aix-Marseille University, Assistance Publique–Hôpitaux de Marseille, Timone Hospital, Marseille, France
-
- Felix Kiecker
- Department of Dermatology, Venereology, and Allergology, Charité Universitätsmedizin Berlin, Edmund-Lesser-Haus, Berlin, Germany
-
- Guilherme Rabinowits
- Dana-Farber Cancer Institute, Boston, Massachusetts
-
- Patrick Terheyden
- Department of Dermatology, Allergology, and Venereology, University of Lübeck, Lübeck, Germany
-
- Isabella Zwiener
- Merck KGaA, Darmstadt, Germany
-
- Marcis Bajars
- EMD Serono, Billerica, Massachusetts
-
- Meliessa Hennessy
- EMD Serono, Billerica, Massachusetts
-
- Howard L. Kaufman
- Rutgers Cancer Institute of New Jersey, New Brunswick
書誌事項
- タイトル別名
-
- A Preplanned Interim Analysis of a Clinical Trial
この論文をさがす
収録刊行物
-
- JAMA Oncology
-
JAMA Oncology 4 (9), e180077-, 2018-09-13
American Medical Association (AMA)